Compass Therapeutics Inc.

The current institutional shareholding score of Compass Therapeutics Inc. is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 90.26%, representing a quarter-over-quarter increase of 28.41%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 3.78M shares, representing 0.90% of shares outstanding, with 77.39% decrease in holdings.